Welcome to BlogNotions' Life Sciences Blog

The BlogNotions Life Sciences Blog delivers a diverse series of perspectives provided by thought leaders in the life sciences industries. Presented by NetLine, this forum delivers compelling updates on the latest technological advances, discussions of research and findings, best practices for advancing education, implications for the future of various life sciences fields, and much more. Here you can find helpful information, ask questions, and collaborate freely.

Hallucinogenic drug offers relief for people with cancer-related anxiety or depression

In continuation of my update on psilocybin In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin — the active compound in hallucinogenic “magic mushrooms.” The researchers cautioned that the […]

Continue Reading

Drug Patent Expirations for Aug 17, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ASMANEX TWISTHALER (mometasone furoate) Merck Sharp Dohme Patent number: 6,240,918 Expiration Date: Aug 20, 2017 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For […]

Continue Reading

Combination treatment produces better outcomes in erythropoietin-refractory MDS patients, study shows

In continuation of my updates  lenalidomide Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of different types of blood cells, including red blood cells leading to the development of anemia. Many patients with lower-risk MDS benefit from treatment with recombinant-erythropoietin (rHuEPO), which stimulates blood cell production. However, patients who become refractory […]

Continue Reading

CBD oil may reduce frequency and severity of seizures in patients with epilepsy, UAB study shows

Cannabidiol oil, also known as CBD oil, reduces the frequency and severity of seizures in children and adults with severe, intractable epilepsy, according to findings presented by researchers from the University of Alabama at Birmingham at the American Epilepsy Society 70th Annual Meeting. UAB researchers presented eleven abstracts, or research findings, at the meeting. A […]

Continue Reading

A Guide to Time Lag and Time Lag Shortening Strategies in Oncology-Based Drug Development

Transformation of a new scientific idea into a new oncology-based drug requires a tremendous amount of time, effort and investment. The initial, but critical first step in this process is transferring basic oncology research into a clinical application known as a “translational” or “bench to bedside study”. As a postdoctoral fellow who performs prostate cancer research related bench work, […]

Continue Reading

Drug Patent Expirations for Aug 10, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AVANDAMET (metformin hydrochloride; rosiglitazone maleate) Sb Pharmco Patent number: 6,288,095 Expiration Date: Aug 11, 2017 ULESFIA (benzyl alcohol) Shionogi Inc Patent number: 6,139,859 Expiration Date: Aug […]

Continue Reading

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease. “Cardiovascular disease is a leading cause of death in adults with type 2 diabetes mellitus,” said Jean-Marc Guettier, M.D., C.M., director of the Division of […]

Continue Reading